Position in BEAM
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$10,784,303
+$1,588,522 QoQ
Shares Held
314,228
-18.6% QoQ
Ownership
0.304%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#39
of 274 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAILLIE GIFFORD & CO holds $3,256,235,173 across 13 Biotechnology names. BEAM ranks #11 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
18,206,778 | $1,275,020,662 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,439,889 | $734,479,783 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,015,578 | $561,573,456 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
11,960,230 | $307,617,113 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
272,561 | $135,389,224 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
23,487,907 | $86,200,617 | |
| 7 | BNTX |
BioNTech SE
|
592,380 | $55,120,957 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
263,466 | $49,341,910 |
All Filings in BEAM
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,784,303 | 314,228 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $9,195,781 | 385,891 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $11,537,728 | 416,224 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $7,227,678 | 297,803 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $5,105,329 | 300,137 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $5,912,393 | 302,734 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $7,644,251 | 308,236 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $8,763,600 | 357,698 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $14,611,883 | 623,640 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $24,859,095 | 752,394 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $20,799,426 | 764,123 | Shares | Defined | 2024-01-26 | |
| 2023-09-30 | $21,061,713 | 875,747 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,722,793 | 523,733 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $13,863,540 | 452,761 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $17,788,320 | 454,828 | Shares | Defined | 2023-03-10 | |
| 2022-09-30 | $18,351,783 | 385,218 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $413,151 | 10,673 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $611,562 | 10,673 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $850,530 | 10,673 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $931,006 | 10,700 | Shares | Defined | 2021-10-19 | |
| 2021-06-30 | $62,681 | 487 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $41,540 | 519 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $40,411 | 495 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||